Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Lam Research (NASDAQ:LRCX) had its price target raised by investment analysts at Stifel Nicolaus from $250.00 to $280.00 in a research note issued to investors on Thursday,MarketScreener reports. The brokerage currently has a “buy” rating on the semiconductor company’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of 14.97% from the company’s previous close.

A number of other analysts have also weighed in on LRCX. Berenberg Bank raised their target price on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Bank of America boosted their price objective on shares of Lam Research from $195.00 to $245.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. UBS Group reaffirmed a “buy” rating and set a $255.00 target price (up from $200.00) on shares of Lam Research in a research report on Tuesday, January 20th. Morgan Stanley set a $211.00 price target on Lam Research in a research report on Thursday, January 15th. Finally, Oppenheimer restated an “outperform” rating and set a $265.00 price objective on shares of Lam Research in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $226.39.

Lam Research Price Performance

Shares of LRCX traded up $3.96 during trading hours on Thursday, hitting $243.54. 3,004,561 shares of the company were exchanged, compared to its average volume of 13,232,577. The firm’s fifty day moving average is $183.31 and its 200 day moving average is $144.37. The company has a market cap of $305.90 billion, a price-to-earnings ratio of 53.79, a P/E/G ratio of 3.01 and a beta of 1.77. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $251.38.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period last year, the firm posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts anticipate that Lam Research will post 3.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Lam Research

In other news, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director owned 1,652 shares in the company, valued at approximately $264,303.48. The trade was a 44.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 41,408 shares of company stock worth $6,248,501. 0.31% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Lam Research

A number of institutional investors have recently made changes to their positions in LRCX. PMV Capital Advisers LLC bought a new stake in shares of Lam Research during the 4th quarter valued at approximately $25,000. IMG Wealth Management Inc. bought a new stake in shares of Lam Research during the 2nd quarter worth $26,000. Stance Capital LLC purchased a new position in Lam Research in the 3rd quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in Lam Research in the 2nd quarter worth approximately $27,000. Finally, Triumph Capital Management purchased a new stake in Lam Research during the third quarter valued at about $27,000. Institutional investors own 84.61% of the company’s stock.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 results beat across the board — Lam reported $1.27 EPS on $5.34B revenue, beating estimates and showing 22% y/y revenue growth; management gave Q3 EPS guidance of $1.25–1.45 and revenue above Street expectations, underpinning the rally. Reuters: Lam Research forecasts strong quarterly results on chipmaking tool demand
• Positive Sentiment: Analysts are upgrading and lifting targets — Needham bumped its target to $300 (Buy), TD Cowen raised its target to $290 (Buy), Summit Insights upgraded to Buy and other shops (Stifel, Evercore) have raised targets — reinforcing upside expectations. (See Benzinga / firm notes for specific upgrades.) Benzinga: Analyst coverage
• Positive Sentiment: Market commentary highlights structural demand drivers — coverage notes Lam is benefiting from AI-led content gains, expanding foundry and NAND investments, and tight supply for its tools. These secular drivers support higher bookings and revenue visibility. InsiderMonkey: Lam Research poised to benefit
• Positive Sentiment: Positive media reaction to earnings — outlets like Barron’s and Zacks called the quarter “extraordinarily bullish” or highlighted the beat, which can attract momentum and fund flows into LRCX. Barron’s: Why earnings were bullish
• Neutral Sentiment: Earnings materials and call transcript are available for detail — investors can review the press release, slide deck and call transcript for bookings, customer cadence and regional commentary. Lam press release/slide deck Call transcript
• Neutral Sentiment: Price action and valuation are mixed — LRCX has rallied strongly over the past year, and some reports simply note new 12?month highs and upgrades without deeper risk analysis. AmericanBankingNews: Analyst-driven move
• Negative Sentiment: Valuation and pullback risk flagged — commentary warns the stock’s rapid run-up increases vulnerability to large corrections and raises questions about whether current multiples fully reflect the recovery. Forbes: Valuation/reality-check piece
• Negative Sentiment: Geopolitical/regional risk remains — coverage notes China-related demand and policy dynamics could weigh on the outlook or produce volatility even amid strong AI-driven demand. MSN: China risks

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.